Now trading at a price of $5.03, Assertio has moved -1.0% so far today.
Assertio shares moved 140.8% over the last 52 weeks, with a high of $7.0 and a low of $1.86. During this time, the stock outperformed the S&P 500 index by 141.0%. As of January 2022, the company's 50-day average price is $6.0. Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inflammation. The small-cap Health Care company has 30 full time employees and is based in Lake Forest, IL. Assertio has not offered any dividends in the last year.
The Company Has Irregular Cash Flows:
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Revenue (k) | $229,504 | $106,275 | $111,014 | $156,234 |
| Revenue Growth | n/a | -53.69% | 4.46% | 40.73% |
| Operating Margins | -0.3% | -44.2% | 9.5% | 37.2% |
| Operating Margins Growth | n/a | -14633.33% | 121.49% | 291.58% |
| Earnings Per Share | -$12.28 | -$1.08 | -$0.03 | $1.59 |
| EPS Growth | n/a | 91.21% | 97.22% | 5400.0% |
| Diluted Shares (MM) | 18 | 26 | 43 | 56 |
| Free Cash Flow (k) | $88,994 | -$65,582 | $5,470 | $78,324 |
| FCF Growth | n/a | -173.69% | 108.34% | 1331.88% |
| Capital Expenditures (k) | -$1,481 | -$10 | -$53 | -$274 |
| Net Debt / EBITDA | -4.96 | -13.18 | 0.95 | 0.03 |
Assertio Shares Are Inexpensive:
Compared to the Health Care sector's average of 24.45, Assertio has a trailing twelve month P/E ratio of 3.2 and, according to its EPS guidance of 0.62, an expected P/E ratio of 8.1. Assertio's PEG ratio is 3.7 based on its 1.0% compound average growth rate of historical and projected earnings per share. This suggests that the company's shares are overvalued.
However, Assertio is likely undervalued in terms of its equity because its P/B ratio is 1.1 compared to its sector average of 4.16. The company's shares are now trading -61.1% below their Graham number, implying there is a margin of safety for the stock. We calculate the number according to this formula:
√(22.5 * EPS * book value per share) = √(22.5 * 1.59 * 4.671) = $12.93
Assertio Is the Subject of Mixed Market Indicators:
4 analysts are following Assertio and have set target prices ranging from $8.0 to $9.5 per share. On average, they have given the company a rating of buy. At the current price of $5.03, ASRT is trading -39.98% away from its average analyst target price of $8.38 per share, implying an analyst consensus of strong upside potential for the stock.
The company has an unusually large proportion of its shares sold short since 17.8% of the company's shares are tied to short positions. Institutions own 34.0% of Assertio's shares, while the insider ownership rate stands at 1.9%. The biggest shareholder is the Vanguard Group, Inc. with a 4% stake in the company worth approximately $11,037,178.
